Pericardial effusion in a 29-year-old HIV(+) man

Laboratory Medicine

Volumn 38, Issue 3, 2007, Pages 150-152

  Shamah, Corey J ^a   Pretell, Judith O ^b   Kroft, Steven H ^b  

^a Division of Neoplastic Diseases   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

AIDS; NonHodgkins lymphoma; Primary effusion lymphoma

Indexed keywords

EID: 34547886695     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/6FVJQ28FK1TKCB0T     Document Type: Article

References (8)

1. Boulanger E, Gerard L, Molina J, et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol. 2005;23:4372-4380.
2. Dotti G, Fiocchi R, Motta T, et al. Primary effusion lymphoma after heart transplantation: A new entity associated with human herpesvirus-8. Leukemia. 1999;13:664.
3. Ely SA, Powers J, Lewis D, et al. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma arising in the subarachnoid space. Human Pathol. 1999;30:981-984.
4. Wilson KS, McKenna RW, Kroft SH, et al. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol. 2002;116:113-121.
5. Jaffe ES, Harris NL, Stein H, et al. editors. World Health Organization Classification of Tumors, Pathology and Genetics, Tumors of the Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001:179-180.
6. Luppi M, Trovato R, Barozzi P, et al. Treatment of herpesvirus associated primary effusion lymphoma with intracavitary cidofovir. Leukemia. 2005;19:473-476.
7. An J, Sun Y, Fisher M, et al. Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia. 2004;18:1699.
8. Simonelli C, Spina M, Cinelli R, et al. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: A single institution study. J Clin Oncol. 2003;21:3948-3954.